New 'gastric bypass pill' causes weight loss without side effects: study
Share this @internewscast.com

A new once-daily pill may raise the bar for weight loss meds.

Drugs like Ozempic and Mounjaro, which imitate the GLP-1 hormone that the body releases post-meal, can lead to notable weight reduction; however, they may also result in the loss of lean muscle mass as a side effect.

Developers of the experimental drug SYNT-101 assert that it replicates the outcomes of gastric bypass surgery while maintaining lean muscle mass more effectively than GLP-1 drugs.

“We are confident that SYNT-101 will offer a convenient, long-term oral solution and/or complement to systemic treatments like GLP-1 drugs,” stated Rahul Dhanda, CEO of Syntis Bio, the biopharmaceutical firm in Boston working on the development of the treatment.

SYNT-101 forms a synthetic film on the surface of the small intestine, shifting nutrient exposure to the lower intestine to promote a feeling of fullness. The lining is designed to work for up to 24 hours before it’s naturally cleared from the body.

In a new first-in-human study, seven women and two men between the ages of 24 and 53, who were not considered obese, took varying doses of SYNT-101 in liquid form.

Imaging confirmed that the coating formed across the upper small intestine, and tissue samples showed that SYNT-101 was safely expelled within 24 hours.

Further testing showed the participants had normal liver functioning and lower glucose absorption.

SYNT-101 promotes better energy balance, Dhanda said, lessening the body’s tendency to break down muscle tissue for fuel.

No serious side effects were reported.

Nausea is one of the most frequently reported side effects of GLP-1 drugs — and one of the major reasons why some users quit taking them.

Hair loss and skin pain are among the less common side effects. Blindness and behavioral changes can occur in very rare cases.

Weight loss was not tracked for this study, but the researchers said the results reflected reduced food consumption.

In rodent studies, SYNT-101 produced weight loss of 1% a week for six weeks while preserving 100% of lean muscle mass.

The new findings were presented this week at the European Congress on Obesity in Malaga, Spain.

“The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and severe side effects that often accompany available treatment options,” Dhanda said.

More research is needed to fully assess the drug’s efficacy and safety.

Syntis Bio plans to submit an Investigational New Drug (IND) application to the Food and Drug Administration later this year.

“We are eager to replicate these data in our upcoming Phase 1 clinical trial and further explore the ability of SYNT-101 to produce sustainable, safe, effective weight loss by reducing fat, preserving lean muscle and stimulating natural production of satiety hormones to prevent weight regain,” Dhanda said.

Share this @internewscast.com
You May Also Like
Colorado man dies after car drives over rim of Grand Canyon National Park

Colorado Man Killed After Vehicle Plunges Over Edge in Grand Canyon National Park

This article covers the topic of suicide. If you or someone you…
Federal agents forced to retreat on slashed tires after immigration raid confrontation in sanctuary city

Federal Agents Withdraw After Immigration Raid in Sanctuary City Leads to Tire Slashing

A dramatic standoff in upstate New York between immigration agents, roofers and…
Charlotte mayor slammed over comments after woman stabbed to death on train

Criticism mounts against Charlotte mayor following remarks post train stabbing incident

Charlotte Mayor Vi Lyles, a Democrat, is under fire for her response…
Trump dines at a restaurant near the White House to promote his DC crime crackdown

Trump visits nearby eatery to highlight his Washington DC crime reduction efforts

WASHINGTON (AP) — On Tuesday evening, President Donald Trump dined at a…
Containers falling off a cargo ship in California

Watch: Shocking Footage of Shipping Containers Falling from Cargo Ship in California

A dramatic video captures the incident where almost 70 shipping containers tumbled…
Jacksonville council tensions rise amid budget debate and walkout

Tensions Escalate in Jacksonville Council During Budget Talks and Walkout

Jacksonville City Council’s meeting turned contentious as members debated amendments blocking funding…
Former Chicago Public Schools CEO Paul Vallas, DePaul University professor weigh in on Nation's Report Card

Ex-Chicago Public Schools CEO Paul Vallas and DePaul University Professor Discuss Nation’s Report Card

CHICAGO (WLS) — A local former education leader and college professor are…
Violent Gen Z protests spiral with at least 19 killed in Nepal; video shows parliament building ablaze

At Least 19 Deaths in Nepal as Gen Z Protests Escalate; Footage Captures Parliament Building on Fire

Protests against the government in Nepal escalated into violence on Tuesday, with…
57 illegal immigrants detained in major New York worksite raid; 5 accused of reentry after deportation

57 Undocumented Immigrants Detained in Significant New York Worksite Raid; 5 Charged with Illegal Reentry After Deportation

A significant federal raid in upstate New York resulted in the arrest…
Ukraine's defenses may collapse under escalating Russian attacks

Ukraine’s Defense Struggles Amid Intensifying Russian Assaults

Ukraine is facing the possibility of running low on air defense weapons…
Chief Justice John Roberts keeps in place President Donald Trump funding freeze that threatens billions in foreign aid

Chief Justice John Roberts Maintains Trump’s Funding Freeze, Risking Billions in Foreign Aid

WASHINGTON — Chief Justice John Roberts on Tuesday temporarily maintained the Trump…
Michigan city may ban LGBTQ+ flags on public property, judge rules

Judge Rules Michigan City Can Consider Banning LGBTQ+ Flags on Public Property

A Michigan city may enforce its rule banning LGBTQ+ flags from being…